SCIACCALUGA, Miriam
SCIACCALUGA, Miriam
DIPARTIMENTO DI MEDICINA E CHIRURGIA
A positive allosteric modulator of mGlu4 receptors restores striatal plasticity in an animal model of l-Dopa-induced dyskinesia
2022 Calabrese, Valeria; Picconi, Barbara; Heck, Nicolas; Campanelli, Federica; Natale, Giuseppina; Marino, Gioia; Sciaccaluga, Miriam; Ghiglieri, Veronica; Tozzi, Alessandro; Anceaume, Estelle; Cuoc, Emeline; Caboche, Jocelyne; Conquet, François; Calabresi, Paolo; Charvin, Delphine
An unbalanced synaptic transmission: Cause or consequence of the amyloid oligomers neurotoxicity?
2021 Sciaccaluga, M.; Megaro, A.; Bellomo, G.; Ruffolo, G.; Romoli, M.; Palma, E.; Costa, C.
Biochemical activity and multiple locations of particulate guanylate cyclase in Rhyacophila dorsalis acutidens (Insecta: Trichoptera) provide insights into the cGMP signaling pathway in Malpighian tubules
2011 Secca, Teresa; Sciaccaluga, M.; Marra, A.; Barberini, Lanfranco; Bicchierai, Maria Clara Rita
Bromopyruvate mediates autophagy and cardiolipin degradation to monolyso-cardiolipin in GL15 glioblastoma cells
2012 Davidescu, Magdalena; Sciaccaluga, Miriam; Macchioni, Lara; R., Angelini; P., Lopalco; Rambotti, Maria Grazia; Roberti, Rita; A., Corcelli; Castigli, Emilia; Corazzi, Lanfranco
Cannabidiol: metabolism and clinical efficacy in epileptic patients
2024 Dell'Isola, Giovanni Battista; Verrotti, Alberto; Sciaccaluga, Miriam; Dini, Gianluca; Ferrara, Pietro; Parnetti, Lucilla; Costa, Cinzia
Chemistry and Pharmacology of a Series of Unichiral Analogues of 2-(2-Pyrrolidinyl)-1,4-benzodioxane, Prolinol Phenyl Ether, and Prolinol 3-Pyridyl Ether Designed as α4β2-Nicotinic Acetylcholine Receptor Agonists
2015 Bolchi, C; Valoti, E; Gotti, C; Fasoli, F; Ruggeri, P; Fumagalli, L; Binda, M; Mucchietto, V; Sciaccaluga, M; Budriesi, R; Fucile, S; Pallavicini, M
Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonism
2020 Martinelli, S.; Cordeddu, V.; Galosi, S.; Lanzo, A.; Palma, E.; Pannone, L.; Ciolfi, A.; Di Nottia, M.; Rizza, T.; Bocchinfuso, G.; Traversa, A.; Caputo, V.; Farrotti, A.; Carducci, C.; Bernardini, L.; Cogo, S.; Paglione, M.; Venditti, M.; Bentivoglio, A.; Ng, J.; Kurian, M. A.; Civiero, L.; Greggio, E.; Stella, L.; Trettel, F.; Sciaccaluga, M.; Roseti, C.; Carrozzo, R.; Fucile, S.; Limatola, C.; Di Schiavi, E.; Tartaglia, M.; Leuzzi, V.
Constitutive phosphorylation of Janus kinase2 in the GL15 glioblastoma derived human cell line
2007 Sciaccaluga, Miriam; Gianfranceschi, Gianluigi; Rocco, S.; Germano, G.; Roti, Giovanni; Gorello, Paolo; LA STARZA, Roberta; Castigli, Emilia
Crucial role of nicotinic α5 subunit variants for Ca2+ fluxes in ventral midbrain neurons
2015 Sciaccaluga, Miriam; Moriconi, Claudia; Martinello, Katiuscia; Catalano, Myriam; Bermudez, Isabel; Stitzel, Jerry A; Maskos, Uwe; Fucile, Sergio
CXCL12-induced glioblastoma cell migration requires intermediate-conductance Ca2+-activated K+ channel activity
2010 Sciaccaluga, Miriam; Fioretti, Bernard; Catacuzzeno, Luigi; Pagani, F; Bertollini, C; Rosito, M; Catalano, M; D'Alessandro, G; Santoro, A; Cantore, G; Ragozzino, D; Castigli, Emilia; Franciolini, Fabio; Limatola, C.
Cytotoxic and genotoxic effects mediated by M2 muscarinic receptor activation in human glioblastoma cells
2015 Di Bari, M; Tombolillo, V; Conte, C; Castigli, E; Sciaccaluga, M; Iorio, E; Carpinelli, G; Ricordy, R; Fiore, M; Degrassi, F; Tata, Am.
Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice
2021 Mossa, A.; Pagano, J.; Ponzoni, L.; Tozzi, A.; Vezzoli, E.; Sciaccaluga, M.; Costa, C.; Beretta, S.; Francolini, M.; Sala, M.; Calabresi, P.; Boeckers, T. M.; Sala, C.; Verpelli, C.
Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit
2021 Tozzi, A.; Sciaccaluga, M.; Loffredo, V.; Megaro, A.; Ledonne, A.; Cardinale, A.; Federici, M.; Bellingacci, L.; Paciotti, S.; Ferrari, E.; La Rocca, A.; Martini, A.; Mercuri, N. B.; Gardoni, F.; Picconi, B.; Ghiglieri, V.; de Leonibus, E.; Calabresi, P.
Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease
2020 Sciaccaluga, M.; Mazzocchetti, P.; Bastioli, G.; Ghiglieri, V.; Cardinale, A.; Mosci, P.; Caccia, C.; Keywood, C.; Melloni, E.; Padoani, G.; Vailati, S.; Picconi, B.; Calabresi, P.; Tozzi, A.
Epilepsy and Alzheimer's Disease: Current Concepts and Treatment Perspective on Two Closely Related Pathologies
2022 Leo, Antonio; Tallarico, Martina; Sciaccaluga, Miriam; Citraro, Rita; Costa, Cinzia
Epm2aR240X knock-in mice present earlier cognitive decline and more epileptic activity than Epm2a-/- mice
2023 Burgos, Daniel F; Sciaccaluga, Miriam; Worby, Carolyn A; Zafra-Puerta, Luis; Iglesias-Cabeza, Nerea; Sánchez-Martín, Gema; Prontera, Paolo; Costa, Cinzia; Serratosa, José M; Sánchez, Marina P
Evaluating bexicaserin for the treatment of developmental epileptic encephalopathies
2024 Dell'Isola, Giovanni Battista; Verrotti, Alberto; Sciaccaluga, Miriam; Roberti, Roberta; Parnetti, Lucilla; Russo, Emilio; Costa, Cinzia
Expression and modulation of the intermediate-conductance Ca 2+ -activated K + channel in glioblastoma GL-15 cells
2006 Fioretti, Bernard; Castigli, Emilia; Micheli, Maria Rita; Bova, Rodolfo; Sciaccaluga, Miriam; Harper, A. A.; Franciolini, Fabio; Catacuzzeno, Luigi
Extracellular mild acidosis decreases the Ca 2+ permeability of the human NMDA receptors
2019 Plutino, S.; Sciaccaluga, M.; Fucile, S.
From pyrrolidinyl-benzodioxane to pyrrolidinyl-pyridodioxanes, or from unselective antagonism to selective partial agonism at α4β2 nicotinic acetylcholine receptor
2016 Bolchi, C; Bavo, F; Gotti, C; Fumagalli, L; Fasoli, F; Binda, M; Mucchietto, V; Sciaccaluga, M; Plutino, S; Fucile, S; Pallavicini, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A positive allosteric modulator of mGlu4 receptors restores striatal plasticity in an animal model of l-Dopa-induced dyskinesia | 2022 | Calabrese, Valeria; Picconi, Barbara; Heck, Nicolas; Campanelli, Federica; Natale, Giuseppina; Marino, Gioia; Sciaccaluga, Miriam; Ghiglieri, Veronica; Tozzi, Alessandro; Anceaume, Estelle; Cuoc, Emeline; Caboche, Jocelyne; Conquet, François; Calabresi, Paolo; Charvin, Delphine | |
| An unbalanced synaptic transmission: Cause or consequence of the amyloid oligomers neurotoxicity? | 2021 | Sciaccaluga, M.; Megaro, A.; Bellomo, G.; Ruffolo, G.; Romoli, M.; Palma, E.; Costa, C. | |
| Biochemical activity and multiple locations of particulate guanylate cyclase in Rhyacophila dorsalis acutidens (Insecta: Trichoptera) provide insights into the cGMP signaling pathway in Malpighian tubules | 2011 | Secca, Teresa; Sciaccaluga, M.; Marra, A.; Barberini, Lanfranco; Bicchierai, Maria Clara Rita | |
| Bromopyruvate mediates autophagy and cardiolipin degradation to monolyso-cardiolipin in GL15 glioblastoma cells | 2012 | Davidescu, Magdalena; Sciaccaluga, Miriam; Macchioni, Lara; R., Angelini; P., Lopalco; Rambotti, Maria Grazia; Roberti, Rita; A., Corcelli; Castigli, Emilia; Corazzi, Lanfranco | |
| Cannabidiol: metabolism and clinical efficacy in epileptic patients | 2024 | Dell'Isola, Giovanni Battista; Verrotti, Alberto; Sciaccaluga, Miriam; Dini, Gianluca; Ferrara, Pietro; Parnetti, Lucilla; Costa, Cinzia | |
| Chemistry and Pharmacology of a Series of Unichiral Analogues of 2-(2-Pyrrolidinyl)-1,4-benzodioxane, Prolinol Phenyl Ether, and Prolinol 3-Pyridyl Ether Designed as α4β2-Nicotinic Acetylcholine Receptor Agonists | 2015 | Bolchi, C; Valoti, E; Gotti, C; Fasoli, F; Ruggeri, P; Fumagalli, L; Binda, M; Mucchietto, V; Sciaccaluga, M; Budriesi, R; Fucile, S; Pallavicini, M | |
| Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonism | 2020 | Martinelli, S.; Cordeddu, V.; Galosi, S.; Lanzo, A.; Palma, E.; Pannone, L.; Ciolfi, A.; Di Nottia, M.; Rizza, T.; Bocchinfuso, G.; Traversa, A.; Caputo, V.; Farrotti, A.; Carducci, C.; Bernardini, L.; Cogo, S.; Paglione, M.; Venditti, M.; Bentivoglio, A.; Ng, J.; Kurian, M. A.; Civiero, L.; Greggio, E.; Stella, L.; Trettel, F.; Sciaccaluga, M.; Roseti, C.; Carrozzo, R.; Fucile, S.; Limatola, C.; Di Schiavi, E.; Tartaglia, M.; Leuzzi, V. | |
| Constitutive phosphorylation of Janus kinase2 in the GL15 glioblastoma derived human cell line | 2007 | Sciaccaluga, Miriam; Gianfranceschi, Gianluigi; Rocco, S.; Germano, G.; Roti, Giovanni; Gorello, Paolo; LA STARZA, Roberta; Castigli, Emilia | |
| Crucial role of nicotinic α5 subunit variants for Ca2+ fluxes in ventral midbrain neurons | 2015 | Sciaccaluga, Miriam; Moriconi, Claudia; Martinello, Katiuscia; Catalano, Myriam; Bermudez, Isabel; Stitzel, Jerry A; Maskos, Uwe; Fucile, Sergio | |
| CXCL12-induced glioblastoma cell migration requires intermediate-conductance Ca2+-activated K+ channel activity | 2010 | Sciaccaluga, Miriam; Fioretti, Bernard; Catacuzzeno, Luigi; Pagani, F; Bertollini, C; Rosito, M; Catalano, M; D'Alessandro, G; Santoro, A; Cantore, G; Ragozzino, D; Castigli, Emilia; Franciolini, Fabio; Limatola, C. | |
| Cytotoxic and genotoxic effects mediated by M2 muscarinic receptor activation in human glioblastoma cells | 2015 | Di Bari, M; Tombolillo, V; Conte, C; Castigli, E; Sciaccaluga, M; Iorio, E; Carpinelli, G; Ricordy, R; Fiore, M; Degrassi, F; Tata, Am. | |
| Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice | 2021 | Mossa, A.; Pagano, J.; Ponzoni, L.; Tozzi, A.; Vezzoli, E.; Sciaccaluga, M.; Costa, C.; Beretta, S.; Francolini, M.; Sala, M.; Calabresi, P.; Boeckers, T. M.; Sala, C.; Verpelli, C. | |
| Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit | 2021 | Tozzi, A.; Sciaccaluga, M.; Loffredo, V.; Megaro, A.; Ledonne, A.; Cardinale, A.; Federici, M.; Bellingacci, L.; Paciotti, S.; Ferrari, E.; La Rocca, A.; Martini, A.; Mercuri, N. B.; Gardoni, F.; Picconi, B.; Ghiglieri, V.; de Leonibus, E.; Calabresi, P. | |
| Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease | 2020 | Sciaccaluga, M.; Mazzocchetti, P.; Bastioli, G.; Ghiglieri, V.; Cardinale, A.; Mosci, P.; Caccia, C.; Keywood, C.; Melloni, E.; Padoani, G.; Vailati, S.; Picconi, B.; Calabresi, P.; Tozzi, A. | |
| Epilepsy and Alzheimer's Disease: Current Concepts and Treatment Perspective on Two Closely Related Pathologies | 2022 | Leo, Antonio; Tallarico, Martina; Sciaccaluga, Miriam; Citraro, Rita; Costa, Cinzia | |
| Epm2aR240X knock-in mice present earlier cognitive decline and more epileptic activity than Epm2a-/- mice | 2023 | Burgos, Daniel F; Sciaccaluga, Miriam; Worby, Carolyn A; Zafra-Puerta, Luis; Iglesias-Cabeza, Nerea; Sánchez-Martín, Gema; Prontera, Paolo; Costa, Cinzia; Serratosa, José M; Sánchez, Marina P | |
| Evaluating bexicaserin for the treatment of developmental epileptic encephalopathies | 2024 | Dell'Isola, Giovanni Battista; Verrotti, Alberto; Sciaccaluga, Miriam; Roberti, Roberta; Parnetti, Lucilla; Russo, Emilio; Costa, Cinzia | |
| Expression and modulation of the intermediate-conductance Ca 2+ -activated K + channel in glioblastoma GL-15 cells | 2006 | Fioretti, Bernard; Castigli, Emilia; Micheli, Maria Rita; Bova, Rodolfo; Sciaccaluga, Miriam; Harper, A. A.; Franciolini, Fabio; Catacuzzeno, Luigi | |
| Extracellular mild acidosis decreases the Ca 2+ permeability of the human NMDA receptors | 2019 | Plutino, S.; Sciaccaluga, M.; Fucile, S. | |
| From pyrrolidinyl-benzodioxane to pyrrolidinyl-pyridodioxanes, or from unselective antagonism to selective partial agonism at α4β2 nicotinic acetylcholine receptor | 2016 | Bolchi, C; Bavo, F; Gotti, C; Fumagalli, L; Fasoli, F; Binda, M; Mucchietto, V; Sciaccaluga, M; Plutino, S; Fucile, S; Pallavicini, M. |